Send to

Choose Destination
Stat Med. 2015 Sep 20;34(21):2971-80. doi: 10.1002/sim.6557. Epub 2015 Jun 17.

Using a latent class model to refine risk stratification in multiple myeloma.

Author information

Cancer Research And Biostatistics (CRAB), Seattle, WA, U.S.A.
Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, U.S.A.


In multiple myeloma research, the GEP70 model is known to be capable of predicting a high risk patient group for disease progression based on the expression levels of 70 selected genes measured at baseline. The model consists of a continuous gene score that is a linear combination of the 70 genes along with a cutoff, such that patients with a score greater than the cutoff are categorized as high risk and otherwise low risk for disease progression. However, the continuous gene score may be confusing at times because of its open range nature. In addition, the present two-group model is sensitive to scores falling close to its cutoff. To facilitate patients' understanding of their prognosis, it is desirable to convert the continuous score into a probability that has an easier interpretation. In this article, we employ a latent class model to address this issue, and we also propose a superior grey zone model to refine the current risk stratification associated with the GEP70 model. Lastly, we demonstrate the robustness of the grey zone model with results from a simulation study.


GEP70; disease progression; grey zone; latent class; myeloma

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center